Our Broad-Ranging Experience
We’ve delivered measurable results across a broad range of brands and companies, including more than 75 brands in 36 categories such as:
- Large, blockbuster brands—LIPITOR
- Smaller, specialty brands—TYZEKA
- Primary care products—ACTONEL and ACIPHEX
- Specialty products—TRACLEER and RAPAMUNE
- Brands for common ailments —KRISTALOSE for constipation
- Oncology brands—YERVOY and NEXAVAR
- Hospital products— ENTEREG and ACETADOTE
- Devices—SilverHawk and Balloon Sinuplasty
- Large companies—BMS and Pfizer
- Smaller companies—Cumberland Pharmaceuticals
The common thread that runs through the entire range of our experience, from cardiovascular and diabetes products to specialty niche products and
complex biologics, is our commitment to engaging target audiences and creating an Immediate Measurable Interaction (IMI). This commitment to IMI lives throughout the product lifecycle—from launches to patent expiry and beyond.
Contact us to learn more about what our past experiences can mean for the future of your brand.
Some of our current engagements include:
BMS selected Roska Healthcare as patient agency-of-record to help support their oncology franchise. Working closely with the brand team, the agency has helped plan, develop, and launch a fully-integrated patient marketing campaign that provides extensive online and offline support to patients and those involved in their care.

Acclarent, a division of Johnson & Johnson, relied on Roska Healthcare to launch a new targeted DTC campaign in support of their Balloon Sinuplasty devices. The campaign features a combination of tactics (TV, radio, outdoor, transit, and paid search) to drive calls, leads, and transfers
(candidates who call a trained physician).

Actelion Pharmaceuticals chose Roska Healthcare to handle all patient marketing and digital promotion for Tracleer, their flagship brand and market leader in the treatment of pulmonary arterial hypertension.

Cumberland Pharmaceuticals contracted Roska Healthcare to handle all marketing communications for all three of their Rx brands—Caldolor,
Acetadote, and Kristalose—leveraging an integrated mix of highly targeted personal and non-personal promotion to affect HCP prescribing patterns.

Pfizer’s vaccine group named Roska Healthcare as digital agency-of-record and leveraged the company’s digital and integrated marketing expertise to launch new products in the US and globally, taking advantage of new digital technologies and mobile applications to support healthcare professionals, consumers, and caregivers.

Merz Pharmaceuticals appointed Roska Healthcare as the agency-of-record for its
neurology franchise, focused on botulinum toxin therapy for the treatment of cervical dystonia and blepharospasm. Working in tandem with Merz, Roska Healthcare
rebranded this therapy in the U.S. and developed a variety of traditional and digital
assets to support the XEOMIN sales team’s efforts.